Skip to main content
Caplight Logo









August Bioservices

August Bioservices

Private
Nashville, TennesseeHealthcare & Life Scienceshttps://www.augustbio.com/

Last Round

Grant

Oct 20, 2023

Total Funding Raised

$89.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

August Bioservices is a pharmaceutical contract development and manufacturing organization (CDMO) that provides drug discovery, development, and manufacturing services for the pharmaceutical and biotechnology industries.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Biotechnology, Clinical Trials, Drug Discovery, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOsterile injectable manufacturingaseptic fill/finishfill/finish servicesinjectable drug manufacturingpharmaceutical manufacturinglyophilization servicesformulation developmentanalytical servicesprocess developmentclinical trial servicesvial fillingsyringe fillingpharma supply chaindrug discovery support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

August Bioservices Comparables

Compare August Bioservices with similar companies based on industry and business-model similarity.

August Bioservices comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
INCOG BioPharma Services
90%
Afton Scientific
90%
Grand River Aseptic Manufacturing
89%

August Bioservices Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 20, 2023
Series BDec 1, 2022
Series A ExtensionMay 27, 2021
Series AJul 16, 2020

Key People

Founding team and executive leadership

Mats Bjoerkman

Chief Financial Officer

Executive Team

Michael Scribner

Chief Operating Officer

Executive Team

August Bioservices Investors

Notable investors and investment history

August Bioservices investors
InvestorRounds
Oak HC/FTSeries A, Series B, Series A Extension
Tennessee Department of Economic and Community DevelopmentGrant
Polaris PartnersSeries B, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2026

    CEO named Healthcare Technology CEO of the Year.

  • Oct 10, 2025

    Investing significant capital in a two-phase expansion project and new facility construction.

August Bioservices Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

August Bioservices Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about August Bioservices's valuation, stock price, and market status.

Firmographic Details

HeadquartersNashville, Tennessee
Employee Range180
Year Founded2017
Last FundingOct 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?